Second Systemic Sclerosis World Congress a Success PDF Print E-mail
Tuesday, 13 March 2012 14:09
Great success for the second Systemic Sclerosis World Congress that was held in February at the Palacio de Congresos de Madrid.

After the positive experience of 2010 in Florence, AIM Group International organised the second edition the congress, on behalf of World Scleroderma Foundation, founded by Alexander Klee, grandson of the great painter Paul Klee, who also a suffers from scleroderma, a so-called "rare" disease with very painful and debilitating effects.

To approach the social aspects of the disease, the Congress opened to the patients’ associations (FESCA - Scleroderma Federation of European Associations) and organized a parallel conference with hundreds of patients who had the opportunity to debate on clinical cases, experiences and opinions with experts and prominent international physicians.

With a qualified program consisting of seventy seven lectures, around sixty oral presentations and three hundred posters, the Congress attracted over 1,300 delegates from around the world: in fact, in addition to a prevalent presence from European countries, some hundred American, Asian and African participants contributed to reinforcing the international nature of the meeting.

At the end of the World Congress, the Scleroderma Foundation, chaired by Prof. Marco Matucci Cerinic, AIM Group International were appointed for the organisation of the next Congress, to be held in Paris in 2014.

Source: Agency & Association (2012), "The World Scleroderma Foundation meets in Madrid for the “Systemic Sclerosis World Congress” organised by AIM Group International"; ITCM

 
More articles :

» Joint Involvement And Aggressive Systemic Sclerosis

Clinical joint involvement is strikingly common in patients with systemic sclerosis () and is associated with a more active and severe disease phenotype, according to an analysis of the world’s largest systemic sclerosis (SSc) registry. proved to...

» Lower Extremity Ulcers in Systemic Sclerosis: Features and Response to Therapy

Victoria K. Shanmugam, MBBS, MRCP; Patricia Price, PhD; Christopher E. Attinger, MD; Virginia D. Steen, MD Non-digital lower extremity ulcers are a difficult to treat complication of scleroderma that is often refractory to therapy. They are a...

» Researchers Identify Core Genetic Switch As A Viable Target For New Scleroderma Treatments

Scleroderma is a rare, autoimmune disease. Often fatal, it causes the fibrosis or thickening of the connective tissue which support the skin and other vital organs within the body, through the overproduction of . The disease currently lacks a cure...

» Endothelin Drugs Benefit Those With Pulmonary Hypertension

Breaking news from has reported that recent research to block the effects of endothelin, a powerful substance that constricts blood vessels and stimulates cell growth, has led to successful treatment of and provides hope for treating other chronic...

» Scleroderma in Children: Emerging Management Issues

Saumya PandaDepartment of Dermatology, KPC Medical College, Kolkata, IndiaDate of Web Publication: 21-Jul-2010Abstract         Scleroderma is a set of rare connective tissue diseases of unknown etiology. It is...

» Apoptosis Modulation as a Promising Target for Treatment of Systemic Sclerosis

St´ephane Chabaud and V´eronique J. MoulinReceived 1 June 2011; Revised 6 July 2011; Accepted 6 July 2011Systemic sclerosis (scleroderma, SSc) is a heterogeneous disease which develops into three forms: limited, intermediate, and diffuse. The...